Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GAO Will Study Impact Of DTC Advertising Under House Medicare Rx Bill

Executive Summary

The General Accounting Office would be directed to assess the impact of FDA's 1997 broadcast advertising guidance under the House Medicare Rx bill

You may also be interested in...



FDA Readies Report On DTC, Says Physician Survey Supports Current Policy

FDA expects to publish a report on its 1997 direct-to-consumer broadcast advertising policy this spring

FDA Readies Report On DTC, Says Physician Survey Supports Current Policy

FDA expects to publish a report on its 1997 direct-to-consumer broadcast advertising policy this spring

Medicare Rx Clears House; Late Changes Include Nod To Pharmacy

The House Republican Medicare prescription drug bill would provide $600 mil. in federal grants to support pharmacy services

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040047

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel